CiVi Biopharma A/S — Credit Rating and Financial Key Figures

CiVi Biopharma A/S (CVR number: 38027794) is a company from KØBENHAVN. The company recorded a gross profit of 3502.1 kDKK in 2023. The operating profit was 401.8 kDKK, while net earnings were -1887.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was 83.4 %, which can be considered excellent but Return on Equity (ROE) was -77.6 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 65.1 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. CiVi Biopharma A/S's liquidity measured by quick ratio was 2.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.